Monica Balzarotti

11PUBLICATIONS
103CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Sep 12, 2025
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial.

Emanuele Zucca, Luca Ceriani, Giovannino Ciccone

|Jan 14, 2025
Large clones of clonal hematopoiesis affect outcome in mantle cell lymphoma: results from the FIL MCL0208 clinical trial.

Simone Ragaini, Anna Galli, Elisa Genuardi

|Aug 19, 2024
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results.

Maurizio Martelli, Luca Ceriani, Giovannino Ciccone

|Jul 29, 2024
Rolling the DICEP on lymphoma salvage treatments? Choose wisely.

Monica Balzarotti, Filippo Bagnoli

|Jan 05, 2024
IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma.

Annarita Conconi, Annalisa Chiappella, Andrés J M Ferreri

Pageof 2

Frequent Collaborators

5 joint publications

Alessandra Tucci

5 joint publications

Simone Ferrero

4 joint publications

Francesco Merli

4 joint publications

Luigi Rigacci